| 1989 |
PTN (HBGF-8) was purified to near homogeneity from bovine uterus as a novel 17 kDa heparin-binding growth factor that binds tightly to cation exchange resins and heparin-Sepharose, and stimulates DNA synthesis (3H-thymidine incorporation) in NIH 3T3 fibroblasts with mitogenic activity comparable to aFGF. |
Protein purification (heparin-Sepharose affinity chromatography, cation exchange), N-terminal amino acid sequencing, mitogenic assay (3H-thymidine incorporation in NIH 3T3 cells) |
Biochemical and biophysical research communications |
High |
2610682
|
| 1991 |
PTN (HBNF) was purified to homogeneity from bovine brain and found to have neurotrophic activity for perinatal rat neurons; C-terminally truncated forms (lacking ~14 or ~22 residues) are generated by proteolysis during extraction, comprising major products in the absence of protease inhibitors. |
Protein purification (pH 4.5 extraction, ammonium sulfate precipitation, cation exchange, heparin-Sepharose, reverse-phase HPLC), amino acid sequencing, SDS-PAGE |
Growth factors (Chur, Switzerland) |
High |
2049182
|
| 1992 |
Recombinant PTN (HBNF) inhibits infectivity of herpes simplex viruses types 1 and 2 and human cytomegalovirus; carboxymethylated HBNF (which retains heparin-binding but not free basic charge) loses antiviral activity, suggesting the mechanism involves competition for cell-surface heparan sulfate proteoglycan binding. |
In vitro antiviral infectivity assay with recombinant HBNF and carboxymethylated HBNF variant |
Biochemical and biophysical research communications |
Medium |
1335242
|
| 1993 |
The human PTN (HBNF) gene spans at least 42 kb and is organized in 5 exons; alternative splicing at the exon 5 acceptor site generates a variant mRNA with a 3-bp deletion, encoding a protein (des-Ala119-HBNF) lacking one alanine residue, which comprises ~20% of total HBNF protein in bovine brain. |
Southern blotting, genomic library screening, cDNA sequencing, protein characterization from bovine brain |
Biochemical and biophysical research communications |
Medium |
8484754
|
| 1999 |
PTN (HARP) forms non-covalent dimers, and dimerization is promoted by heparin and other sulfated glycosaminoglycans (dermatan sulfate, chondroitin sulfate-C); chlorate treatment of cells (which inhibits sulfation) blocks dimer formation; PTN is secreted as a dimer in conditioned medium of NIH-3T3 cells overexpressing PTN. |
DSS cross-linking, heparin-Sepharose affinity chromatography, chlorate treatment, conditioned medium analysis |
Biochemical and biophysical research communications |
Medium |
10600521
|
| 2000 |
A human endogenous retrovirus-like element (HERV-E.PTN) inserted into the PTN gene generates a novel promoter driving PTN expression in choriocarcinoma and trophoblast cells; a Sp1-binding site within the retroviral enhancer (+443 to +486) is essential for this promoter activity, as shown by site-specific mutation abolishing activity and Sp1 overexpression in Drosophila SL2 cells confirming Sp1-dependent activation. |
In situ hybridization, transient transfection promoter assays, deletion analysis, EMSA/supershift, site-directed mutagenesis, Sp1 overexpression in SL2 cells |
Oncogene |
High |
10962555
|
| 2005 |
PTN and SDF-1 expression in dermal fibroblasts is regulated by the AP-1 transcription factor JUN; fibroblast-secreted PTN exerts a mitogenic (proliferative) effect on primary human keratinocytes in a heterologous feeder layer co-culture system; PTN expression is upregulated during cutaneous wound healing in vivo. |
Gene expression profiling of Jun-/- vs wild-type MEFs, semi-quantitative RT-PCR, in situ hybridization on skin sections, heterologous feeder layer co-culture keratinocyte proliferation assay, in vivo wound healing model |
Journal of cell science |
Medium |
15840658
|
| 2009 |
IFN-γ markedly induces PTN mRNA expression in macrophages through the JAK/STAT1 signaling pathway; a gamma-activated sequence (GAS) at -2086 to -2078 bp in the PTN promoter is essential for IFN-γ-regulated promoter activity; STAT1 (but not STAT3 or p42) is required for PTN expression, as shown by siRNA knockdown; STAT1 and STAT3 bind to the GAS element at the chromatin level. |
JAK inhibitor treatment (WHI-P154, ATA), STAT1 phosphorylation assays, PTN promoter deletion analysis, EMSA, supershift assay, ChIP, siRNA knockdown of STAT1/STAT3/p42 |
FASEB journal |
High |
19917672
|
| 2010 |
Menin represses PTN transcription and indirectly reduces RPTP β/ζ expression; PTN/RPTP β/ζ signaling promotes A549 lung cancer cell migration in conjunction with integrin αvβ3, focal adhesion kinase (FAK), PI3K, and phosphorylated ERK1/2; ectopic menin expression significantly represses PTN-mediated cell migration. |
Ectopic menin overexpression, RT-PCR for PTN and RPTP β/ζ, cell migration assay, pathway inhibitor studies (PI3K inhibitor, ERK inhibitor), integrin αvβ3 blocking |
Oncogene |
Medium |
20639902
|
| 2012 |
Endogenous PTN in mammary epithelial cells (MECs) promotes motility and invasion (but not proliferation) as demonstrated by anti-PTN blocking antibody; PTN inhibits expansion and differentiation of epithelial progenitor cells by disrupting cell-matrix adhesion; in vivo, PTN inhibits ductal outgrowth and branching via inhibition of phospho-ERK1/2 signaling in mammary epithelial cells. |
Anti-PTN blocking antibody treatment, real-time impedance monitoring (RTCA), 3D culture mammosphere assay, in vivo mammary gland analysis, Western blotting for phospho-ERK1/2 |
PloS one |
Medium |
23077670
|
| 2013 |
PTN activates anaplastic lymphoma kinase (ALK) via 'Ligand Independent Activation': PTN binds and inactivates the phosphatase activity of its receptor RPTPβ/ζ; inactivated RPTPβ/ζ can no longer dephosphorylate phosphotyrosine sites in the ALK activation domain, resulting in ALK autophosphorylation and autoactivation; this PTN/RPTPβ/ζ pathway also coordinately regulates tyrosine phosphorylation of other downstream proteins. |
Review/mechanistic synthesis of experimental findings (phosphatase activity assays, tyrosine phosphorylation studies of ALK cited in reviewed papers) |
Biochimica et biophysica acta |
Medium |
23777859
|
| 2014 |
PTN is expressed, produced, and secreted by epithelial ovarian cancer (EOC) cells; siRNA-mediated knockdown of PTN or its receptor PTPRZ1 induces significant apoptosis; PTN signaling in EOC cells activates MAPK family members as downstream effectors, as identified by expression profiling of 36 survival-related genes after PTN knockdown. |
siRNA knockdown, Western blot, ELISA, cell viability assay, expression profiling of 36 survival genes, computational pathway mapping |
Molecular carcinogenesis |
Medium |
25418856
|
| 2017 |
In uterine stromal cells, progesterone stimulates PTN expression via cAMP/PKA/C/EBPβ pathway; PTN acts downstream of C/EBPβ to promote decidualization marker expression (Prl8a2, Prl3c1); PTN mediates C/EBPβ regulation of Hand2, a downstream target in uterine stromal cell differentiation. |
siRNA knockdown of PTN and C/EBPβ, constitutive PTN activation, PKA inhibitor (H89) treatment, RT-PCR for decidualization markers, progesterone/cAMP treatment of uterine stromal cells |
Journal of cellular physiology |
Medium |
28657144
|
| 2018 |
Adult hippocampal neural stem cells (NSCs) continuously supply PTN as a feedforward signal to newborn neurons; ablation of NSCs or loss of PTN signaling causes defective dendritic development and arborization in newborn neurons. |
Cell ablation, retrovirus-mediated single-cell labeling, signaling pathway modulation, morphological analysis of newborn neurons |
Neuron |
High |
30497772
|
| 2018 |
Chemotherapy (in TNBC cells) drives upregulation of PTN and PTPRZ1 expression via CDKN1A; elevated PTN/PTPRZ1 promotes chemoresistance by activating the NF-κB pathway, enhancing tumor proliferation and inhibiting apoptosis; siRNA knockdown of PTPRZ1 revealed its role in this pathway. |
Microarray analysis, CCK-8 assay, colony formation, apoptosis analysis, siRNA knockdown, pathway inhibition |
Cell communication and signaling |
Medium |
30497491
|
| 2019 |
PTN-PTPRZ signaling promotes oligodendrocyte precursor cell (OPC) differentiation by enhancing tyrosine phosphorylation of AFAP1L2; PTPRZ dephosphorylates AFAP1L2 at tyrosine residues in vitro and in HEK293T cells; PTN-induced AFAP1L2 phosphorylation activates the PI3K-AKT-mTOR pathway; knock-in mice with catalytically inactive PTPRZ (Cys-to-Ser mutation) show enhanced OPC differentiation and earlier remyelination. |
Phosphoproteomics in OPC-like OL1 cells, in vitro PTPRZ phosphatase assay, HEK293T overexpression, siRNA knockdown of AFAP1L2, PI3K inhibitor treatment, Cys-to-Ser knock-in mice, cuprizone demyelination model |
Glia |
High |
30667096
|
| 2021 |
PTN promotes neurite outgrowth from dorsal root ganglion (DRG) neurons; shRNA-mediated knockdown of PTN in pancreatic cancer BxPC-3 cells reduces PTN expression and inhibits neurite outgrowth from co-cultured DRG neurons. |
Adenovirus-mediated shRNA knockdown, RT-PCR, immunocytochemistry, Western blot, DRG co-culture neurite morphology assay |
World journal of gastroenterology |
Medium |
21677838
|
| 2024 |
PTN secreted by Leydig cells activates syndecan-2 (SDC2) on spermatogonial stem cells (SSCs); SDC2 knockdown impairs SSC proliferation, DNA synthesis, PLZF expression, and downregulates GFRA1 and HIF-1 signaling; exogenous PTN rescues proliferation and GFRA1 expression in SDC2 knockdown SSC lines; protein immunoprecipitation confirmed the PTN-SDC2 interaction. |
Single-cell sequencing data analysis, immunofluorescence, STRING prediction, protein immunoprecipitation, SDC2 knockdown, transcriptome analysis, exogenous PTN rescue experiment |
Biological research |
Medium |
39285301
|
| 2024 |
Astrocyte-derived PTN promotes hippocampal neurogenesis and cognition by signaling through PTPRZ1 or ALK receptors to activate AKT signaling; conditional deletion of PTN in astrocytes exacerbates neurogenic deficits in demyelinated hippocampus; PTN overexpression in astrocytes reverses neurogenic and cognitive impairments caused by demyelination. |
Conditional knockout (astrocyte-specific PTN deletion), PTN overexpression, AKT signaling pathway analysis, neurogenesis assays, behavioral cognitive testing, demyelination model |
Stem cell reports |
High |
39729991
|
| 2024 |
PTN binds to PTPRZ1 receptor on rat bone marrow mesenchymal stem cells (rBMSCs), induces PLCG1 phosphorylation and NCOA3 nuclear translocation, reduces cellular reactive oxygen species (ROS), and thereby promotes osteogenic differentiation and inhibits apoptosis; PTN promotes fracture healing in osteoporotic animals in vivo. |
Phosphorylation quantitative proteomics, immunofluorescence, ALP detection, TUNEL assay, RNA sequencing, in vivo fracture healing in osteoporosis rats |
Biomedicines |
Medium |
40149671
|
| 2024 |
TRAPPC12 interacts with Mea6/cTAGE5 and together they regulate PTN secretion from oligodendrocyte precursor cells (OPCs); Mea6/cTAGE5 ablation disrupts COPII trafficking components (SEC13, SEC31A, SAR1) and impairs PTN secretion; exogenous PTN supplementation rescues OPC differentiation deficits caused by Mea6 deficiency. |
Co-immunoprecipitation (TRAPPC12-Mea6 interaction), conditional knockout (Mea6 cKO in OPCs), COPII component localization/expression analysis, PTN secretion assay, exogenous PTN rescue experiment |
iScience |
High |
38439956
|
| 2025 |
PTN secreted by cardiac fibroblasts promotes fibroblast self-proliferation/invasion and stimulates macrophage inflammatory responses (TNF-α, IL-6, Cox-2) through binding to syndecan-4 (SDC4) receptor, contributing to pressure overload-induced hypertrophic cardiomyopathy. |
Single-cell RNA-seq analysis (scRNA-seq), CellChat cell-cell interaction analysis, in vitro validation (RT-qPCR, EdU staining, transwell assay), in vivo TAC mouse model (Western blot, immunofluorescence, echocardiography) |
Life sciences |
Medium |
39765325
|
| 2025 |
Excessive PTN released by dysregulated quiescent neural stem cells (qNSCs) contributes to manic-like phenotypes in Shank3-overexpressing mice; pharmacological and molecular inhibition of PTN in qNSCs rescues aberrant neurogenesis and alleviates manic-like social deficits. |
Single-cell RNA sequencing (scRNA-seq), pharmacological PTN inhibition, molecular knockdown of PTN in qNSCs, behavioral assays, neurogenesis analysis |
Nature communications |
Medium |
40069581
|
| 2025 |
PTN directly binds to SIRT1 and activates AMPK phosphorylation at Thr172, triggering the AMPK-PGC1α axis to reprogram mitochondrial energy metabolism; PTN overexpression reduces mitochondrial oxidative stress and apoptosis in cardiomyocytes treated with doxorubicin. |
PTN-SIRT1 binding assay, Western blot for AMPK phosphorylation (Thr172) and PGC1α, PTN overexpression, flow cytometry for ROS/apoptosis, in vivo cardiotoxicity model |
Acta biochimica et biophysica Sinica |
Low |
41640280
|
| 2025 |
Androgen receptor (AR) signaling in prostate stroma controls a PTN-mediated extrinsic signaling pathway that regulates monounsaturated fatty acid (MUFA) phospholipid biosynthesis and GPX4 expression to suppress prostate epithelial ferroptosis after castration. |
In vivo analyses in genetically-engineered mice, human organotypic cultures, ferroptosis assays, castration model |
bioRxivpreprint |
Medium |
|
| 2014 |
CART (cocaine- and amphetamine-regulated transcript) neuropeptide facilitates neurite outgrowth in cortical neurons after oxygen-glucose deprivation through a PTN-dependent pathway; siRNA-mediated PTN knockdown abolishes the CART-stimulated increase in GAP43 protein levels. |
siRNA knockdown of PTN, Western blot for GAP43, post-OGD CART treatment, primary mouse cortical neuron culture |
Neuroscience |
Medium |
25010400
|